BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 25040634)

  • 1. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.
    Li J; Li X; Xu W; Wang S; Hu Z; Zhang Q; Deng X; Wang J; Zhang J; Guo C
    Liver Int; 2015 Apr; 35(4):1222-33. PubMed ID: 25040634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol prevents liver cirrhosis by inhibiting hepatic stellate cell activation mediated by the PDGFR/Akt pathway.
    Ding Q; Li Z; Liu B; Ling L; Tian X; Zhang C
    Hum Pathol; 2018 Jun; 76():37-46. PubMed ID: 29514109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
    Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
    J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
    Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
    Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrotic effects of tanshinol in experimental hepatic fibrosis by targeting PI3K/AKT/mTOR/p70S6K1 signaling pathways.
    Peng R; Wang S; Wang R; Wang Y; Wu Y; Yuan Y
    Discov Med; 2017 Feb; 23(125):81-94. PubMed ID: 28371611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Therapeutic Mechanisms of Propolis Against CCl
    Badr G; Sayed EA; Waly H; Hassan KA; Mahmoud MH; Selamoglu Z
    Cell Physiol Biochem; 2019; 53(2):301-322. PubMed ID: 31343125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway.
    Cai S; Wu L; Yuan S; Liu G; Wang Y; Fang L; Xu D
    Eur J Pharmacol; 2021 May; 898():173982. PubMed ID: 33647257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amygdalin inhibits TGFβ1-induced activation of hepatic stellate cells (HSCs) in vitro and CCl
    Wang R; Zhang D; Tang D; Sun K; Peng J; Zhu W; Yin S; Wu Y
    Int Immunopharmacol; 2021 Jan; 90():107151. PubMed ID: 33296784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gambogic acid attenuates liver fibrosis by inhibiting the PI3K/AKT and MAPK signaling pathways via inhibiting HSP90.
    Yu Z; Jv Y; Cai L; Tian X; Huo X; Wang C; Zhang B; Sun C; Ning J; Feng L; Zhang H; Ma X
    Toxicol Appl Pharmacol; 2019 May; 371():63-73. PubMed ID: 30953615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib.
    Liu Y; Wang Z; Kwong SQ; Lui ELH; Friedman SL; Li FR; Lam RWC; Zhang GC; Zhang H; Ye T
    J Hepatol; 2011 Sep; 55(3):612-625. PubMed ID: 21251937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling.
    Liu Y; Wang Z; Wang J; Lam W; Kwong S; Li F; Friedman SL; Zhou S; Ren Q; Xu Z; Wang X; Ji L; Tang S; Zhang H; Lui EL; Ye T
    Liver Int; 2013 Apr; 33(4):504-15. PubMed ID: 23279742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tormentic acid inhibits hepatic stellate cells activation via blocking PI3K/Akt/mTOR and NF-κB signalling pathways.
    Lin X; Li Y; Zhang X; Wei Y; Wen S; Lu Z; Huang Q; Wei J
    Cell Biochem Funct; 2021 Jan; 39(1):77-87. PubMed ID: 32564421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258.
    Liu Y; Wen XM; Lui EL; Friedman SL; Cui W; Ho NP; Li L; Ye T; Fan ST; Zhang H
    Lab Invest; 2009 Oct; 89(10):1152-60. PubMed ID: 19668241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production.
    Wang H; Zhang H; Zhang Y; Wang D; Cheng X; Yang F; Zhang Q; Xue Z; Li Y; Zhang L; Yang L; Miao G; Li D; Guan Z; Da Y; Yao Z; Gao F; Qiao L; Kong L; Zhang R
    Oncotarget; 2016 Dec; 7(50):82864-82875. PubMed ID: 27756878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver.
    He W; Shi F; Zhou ZW; Li B; Zhang K; Zhang X; Ouyang C; Zhou SF; Zhu X
    Drug Des Devel Ther; 2015; 9():3989-4104. PubMed ID: 26347199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.
    Shi Z; Ren M; Rockey DC
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G504-G517. PubMed ID: 31928221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β1 up-regulates the expression of PDGF-β receptor mRNA and induces a delayed PI3K-, AKT-, and p70(S6K) -dependent proliferative response in activated hepatic stellate cells.
    Shah R; Reyes-Gordillo K; Arellanes-Robledo J; Lechuga CG; Hernández-Nazara Z; Cotty A; Rojkind M; Lakshman MR
    Alcohol Clin Exp Res; 2013 Nov; 37(11):1838-48. PubMed ID: 23895226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways.
    Fang L; Zhan S; Huang C; Cheng X; Lv X; Si H; Li J
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):713-25. PubMed ID: 23958495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.
    Paik YH; Kim JK; Lee JI; Kang SH; Kim DY; An SH; Lee SJ; Lee DK; Han KH; Chon CY; Lee SI; Lee KS; Brenner DA
    Gut; 2009 Nov; 58(11):1517-27. PubMed ID: 19201774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loureirin B ameliorates cholestatic liver fibrosis via AKT/mTOR/ATG7-mediated autophagy of hepatic stellate cells.
    Cheng WY; Zeng XX; Cheng P; Zhang JX
    Eur J Pharmacol; 2024 May; 971():176552. PubMed ID: 38580181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.